"NPOs have greater μ-opioid receptor activation than morphine and fentanyl, that has Earlier been demonstrated by an in vitro analyze which pharmacologically evaluated ten nitazenes utilizing two mobile-centered β-arrestin2/mini-Gi recruitment assays monitoring μ-opioid receptor acti